Literature DB >> 27235314

Should High-Frequency Ventilation in the Adult Be Abandoned?

Albert P Nguyen1, Ulrich H Schmidt2, Neil R MacIntyre3.   

Abstract

High-frequency oscillatory ventilation (HFOV) can improve ventilation-perfusion matching without excessive alveolar tidal stretching or collapse-reopening phenomenon. This is an attractive feature in the ventilation of patients with ARDS. However, two recent large multi-center trials of HFOV failed to show benefits in this patient population. The following review addresses whether, in view of these trails, HFOV should be abandoned in the adult population?
Copyright © 2016 by Daedalus Enterprises.

Entities:  

Keywords:  acute respiratory failure; high-frequency oscillatory ventilation

Mesh：

Year:  2016        PMID： 27235314     DOI： 10.4187/respcare.04584

Source DB:  PubMed          Journal:  Respir Care        ISSN： 0020-1324            Impact factor:   2.258


  4 in total

1.  Gas Exchange Mechanism of High Frequency Ventilation: A Brief Narrative Review and Prospect.

Authors:  Yueyang Yuan; Yuqing Chen; Li Zhou; Wei Liu; Zheng Dai
Journal:  J Shanghai Jiaotong Univ Sci       Date:  2022-05-16

Review 2.  The Physiological Basis of High-Frequency Oscillatory Ventilation and Current Evidence in Adults and Children: A Narrative Review.

Authors:  Andrew G Miller; Herng Lee Tan; Brian J Smith; Alexandre T Rotta; Jan Hau Lee
Journal:  Front Physiol       Date:  2022-04-26       Impact factor: 4.755

3.  Expiratory high-frequency percussive ventilation: a novel concept for improving gas exchange.

Authors:  Ferenc Peták; Gergely H Fodor; Álmos Schranc; Roberta Südy; Ádám L Balogh; Barna Babik; André Dos Santos Rocha; Sam Bayat; Davide Bizzotto; Raffaele L Dellacà; Walid Habre
Journal:  Respir Res       Date:  2022-10-15

4.  Quantifying Regional Lung Deformation Using Four-Dimensional Computed Tomography: A Comparison of Conventional and Oscillatory Ventilation.

Authors:  Jacob Herrmann; Sarah E Gerard; Wei Shao; Monica L Hawley; Joseph M Reinhardt; Gary E Christensen; Eric A Hoffman; David W Kaczka
Journal:  Front Physiol       Date:  2020-02-20       Impact factor: 4.566
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.